X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
adult (9) 9
female (9) 9
index medicus (7) 7
male (7) 7
middle aged (6) 6
double-blind method (5) 5
adolescent (4) 4
double-blind (4) 4
analysis (3) 3
dose-response relationship, drug (3) 3
psychiatry (3) 3
usage (3) 3
activation (2) 2
amplification (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, murine-derived (2) 2
anxiety (2) 2
association (2) 2
atmospheric energetics (2) 2
biology (2) 2
blood glucose - drug effects (2) 2
blood glucose - metabolism (2) 2
convection (2) 2
dextrose (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diabetes mellitus, type 2 - drug therapy (2) 2
diabetes mellitus, type 2 - metabolism (2) 2
disability (2) 2
disease (2) 2
drug therapy (2) 2
dual gip/glp-1 agonist (2) 2
dual gip/glp‐1 agonist (2) 2
dynamics (2) 2
eddy kinetic energy (2) 2
endocrinology & metabolism (2) 2
energy conversion (2) 2
fluoxetine (2) 2
fluoxetine - administration & dosage (2) 2
fluoxetine - adverse effects (2) 2
force and energy (2) 2
gastric inhibitory polypeptide - agonists (2) 2
gip (2) 2
gip protein (2) 2
glucagon (2) 2
glucagon-like peptide 1 (2) 2
glucagon-like peptide 1 - agonists (2) 2
glucose (2) 2
hypoglycemia (2) 2
hypoglycemic agents - administration & dosage (2) 2
hypoglycemic agents - pharmacokinetics (2) 2
immunological tolerance (2) 2
insulin (2) 2
intraseasonal oscillation (2) 2
kinetic energy (2) 2
magnetic resonance imaging (2) 2
medical imaging (2) 2
medicine, general & internal (2) 2
meteorology & atmospheric sciences (2) 2
methods (2) 2
monoclonal-antibody (2) 2
multicenter (2) 2
multiple sclerosis, relapsing-remitting - drug therapy (2) 2
multiple sclerosis, relapsing-remitting - immunology (2) 2
multiple sclerosis, relapsing-remitting - pathology (2) 2
nausea (2) 2
neurosciences (2) 2
nnc0090-2746 (2) 2
nnc0090‐2746 (2) 2
organizations (2) 2
patients (2) 2
pediatrics (2) 2
peptides (2) 2
pharmacodynamics (2) 2
pharmacokinetics (2) 2
placebo-controlled trial (2) 2
polypeptides (2) 2
pregnancy (2) 2
psychiatric status rating scales (2) 2
rainfall (2) 2
rg7697 (2) 2
rituximab (2) 2
ro6811135 (2) 2
secretion (2) 2
single-blind method (2) 2
studies (2) 2
summer (2) 2
treatment outcome (2) 2
type 2 diabetes (2) 2
velocity (2) 2
vertical velocities (2) 2
vortices (2) 2
abridged index medicus (1) 1
accuracy (1) 1
actors (1) 1
advection (1) 1
aged (1) 1
alkaline (1) 1
angiotensin-converting enzyme (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Fertility and Sterility, ISSN 0015-0282, 09/2019, Volume 112, Issue 3, pp. e146 - e146
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2007, Volume 46, Issue 11, pp. 1454 - 1463
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2008, Volume 358, Issue 7, pp. 676 - 688
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2017, Volume 19, Issue 10, pp. 1436 - 1445
Aims To investigate the pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of RG7697, a dual glucose‐dependent insulinotropic... 
RG7697, RO6811135 | NNC0090‐2746 | pharmacodynamics | safety | pharmacokinetics | type 2 diabetes mellitus | dual GIP/GLP‐1 agonist | NNC0090-2746 | dual GIP/GLP-1 agonist | ACTIVATION | RO6811135 | RECEPTOR AGONISTS | QTC INTERVAL | GIP | RESPONSES | GLUCAGON-LIKE PEPTIDE-1 | BIOLOGY | ENDOCRINOLOGY & METABOLISM | SECRETION | GASTRIC-INHIBITORY POLYPEPTIDE | RG7697 | ASSOCIATION | Gastric Inhibitory Polypeptide - agonists | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Humans | Middle Aged | Drugs, Investigational - pharmacokinetics | Male | Diabetes Mellitus, Type 2 - metabolism | Blood Glucose - drug effects | Dose-Response Relationship, Drug | Hypoglycemic Agents - administration & dosage | Glucagon-Like Peptide 1 - agonists | Drugs, Investigational - administration & dosage | Adult | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Complications and side effects | Safety and security measures | Peptides | Low density lipoproteins | Glycosylated hemoglobin | Glucose | Dextrose | Appetite | Pharmacodynamics | Fasting | Polypeptides | Glucagon | Diabetes mellitus | Body weight | Diarrhea | Gastric emptying | Nausea | GIP protein | Hypoglycemia | Insulin | Immunological tolerance | Hemoglobin | Diabetes | Pharmacokinetics | Glucagon-like peptide 1
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2017, Volume 19, Issue 10, pp. 1446 - 1453
Journal Article
Journal Article
Journal Article
Journal of the Indian Chemical Society, ISSN 0019-4522, 04/1996, Volume 73, Issue 4-5, pp. 159 - 161
Kinetics of oxidation of L-cysteine by one-electron oxidant, potassium hexacyanoferrate(III) have been investigated spectrophotometrically at 420 nm as a... 
CHEMISTRY | ALKALINE
Journal Article
Neuroendocrinology, ISSN 0028-3835, 1989, Volume 50, Issue 2, pp. 240 - 240
Journal Article